Bioaffinity Technologies, Inc.盘中异动股价大跌5.16%

自选股智能写手03-20

北京时间2024年03月20日03时25分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下跌5.16%。截至发稿，该股报2.02美元/股，成交量22.1484万股，换手率1.99%，振幅5.16%。最近的财报数据显示，该股实现营业收入298484.00美元，净利润-2.29百万美元，每股收益-0.26美元，毛利166211.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2420120220?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-20 03:25","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2420120220","market":"us","top_or_hot":-1,"title":"Bioaffinity Technologies, Inc.盘中异动 股价大跌5.16%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月20日03时25分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下跌5.16%。截至发稿，该股报2.02美元/股，成交量22.1484万股，换手率1.99%，振幅5.16%。最近的财报数据显示，该股实现营业收入298484.00美元，净利润-2.29百万美元，每股收益-0.26美元，毛利166211.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320032550861df792&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioaffinity Technologies, Inc.盘中异动 股价大跌5.16%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioaffinity Technologies, Inc.盘中异动 股价大跌5.16%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-20 03:25 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320032550861df792&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月20日03时25分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下跌5.16%。截至发稿，该股报2.02美元/股，成交量22.1484万股，换手率1.99%，振幅5.16%。最近的财报数据显示，该股实现营业收入298484.00美元，净利润-2.29百万美元，每股收益-0.26美元，毛利166211.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320032550861df792&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIAF","symbol_name":"bioAffinity Technologies, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320032550861df792&s=b","article_id":"2420120220","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320032550861df792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2420120220","pubTimestamp":1710876350,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月20日03时25分，Bioaffinity Technologies, Inc.股票出现异动，股价快速下跌5.16%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.35%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Xwell, Inc.、Neuronetics, Inc.涨幅较大，T2 Biosystems, Inc.、Ispecimen Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为7.04%、2.43%、1.99%，振幅较大的相关个股有Prenetics Global Limited C/Wts 18/05/2027 、Bioaffinity Technologies Inc C/Wts 07/09/2027 、T2 Biosystems, Inc.，振幅分别为56.79%、56.28%、17.55%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力满足于对早期癌症和肺部疾病的非侵入性诊断和靶向癌症治疗的需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BIAF":"bioAffinity Technologies, Inc.","BK4139":"生物科技"},"translate_title":"Bioaffinity Technologies, Inc. tumbled 5.16% in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIAF":0.9},"content_text":"北京时间2024年03月20日03时25分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下跌5.16%。截至发稿，该股报2.02美元/股，成交量22.1484万股，换手率1.99%，振幅5.16%。最近的财报数据显示，该股实现营业收入298484.00美元，净利润-2.29百万美元，每股收益-0.26美元，毛利166211.00美元，市盈率-4.76倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.35%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 (To Pur Com)、Xwell, Inc.、Neuronetics, Inc.涨幅较大，T2 Biosystems, Inc.、Ispecimen Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为7.04%、2.43%、1.99%，振幅较大的相关个股有Prenetics Global Limited C/Wts 18/05/2027 (To Pur Com)、Bioaffinity Technologies Inc C/Wts 07/09/2027 (To Pur Com)、T2 Biosystems, Inc.，振幅分别为56.79%、56.28%、17.55%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力满足于对早期癌症和肺部疾病的非侵入性诊断和靶向癌症治疗的需求。该公司开发了专利的非侵入性诊断测试和癌症治疗技术，优先针对癌症细胞和细胞群指示疾病状态。该公司参与开发的技术，在未来将能够检测和监测肺部疾病和其他癌症，并治疗许多癌症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420120220"}

Bioaffinity Technologies, Inc.盘中异动 股价大跌5.16%

精彩评论

Bioaffinity Technologies, Inc.盘中异动股价大跌5.16%